Bret Wehrli

Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial

Anthony C. Nichols, Julie Theurer, Eitan Prisman et al. · The Lancet Oncology · 2019 · 445 citations

Surgical Oncology, Radiation Therapy, Neck Dissection +8

Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice

Jonathan A. Hill, David Bell, William Brintnell et al. · The Journal of Experimental Medicine · 2008 · 270 citations · Full text

Class Ii, Dr4-ie Transgenic Mice, Immunology +18

Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors

Bret Wehrli, Wendong Huang, Benoît De Crombrugghe et al. · Human Pathology · 2003 · 207 citations

Developmental Biology, Bone Morphogenic Protein, Mesenchymal Chondrosarcoma +8

Giant Cell Tumors of Soft Tissue

John X. OʼConnell, Bret Wehrli, G. Petur Nielsen et al. · The American Journal of Surgical Pathology · 2000 · 156 citations

Primary Gcts, Tumoral Pathology, Malignant Gcts +8

Early-stage squamous cell carcinoma of the oropharynx: Radiotherapy vs. Trans-Oral Robotic Surgery (ORATOR) – study protocol for a randomized phase II trial

Anthony C. Nichols, John Yoo, J. Alex Hammond et al. · BMC Cancer · 2013 · 140 citations · Full text

Surgical Oncology, Cancer Management, Surgery +19